Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine

Neuroscience

Volumn 91, Issue 2, 1999, Pages 527-535

  Zheng, P ^a   Zhang, X X ^a   Bunney, B S ^a   Shi, W X ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic drag; cAMP; Dopamine; NMDA; Prefrontal cortex; Schizophrenia

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYCLIC AMP; DIZOCILPINE MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; ETICLOPRIDE; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; QUINPIROLE; SCH 31966; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINE BRAIN LEVEL; MALE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BINDING; SCHIZOPHRENIA;

1-METHYL-3-ISOBUTYLXANTHINE; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZAZEPINES; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMBRANE POTENTIALS; PREFRONTAL CORTEX; PYRAMIDAL CELLS; QUINOXALINES; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032933406     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00604-6     Document Type: Article

References (61)

1. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E. Jr., Jones E.G. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16:1996;19-30.
2. 2 dopamine receptor-mediated inhibition of a hyperpolarization-activated current in rod photoreceptors. J. Neurophysiol. 76:1996;1828-1835.
3. Benes F.M., Sorensen I., Vincent S.L., Bird E.D., Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cerebr. Cortex. 2:1992;503-512.
4. 2) receptors: a study of the actions of dopamine on corticostriatal transmission. Neuroscience. 10:1983;349-355.
5. Bunney B.S., Aghajanian G.K. Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci. 19:1976;1783-1789.
6. Cepeda C., Buchwald N.A., Levine M.S. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. natn. Acad. Sci. U.S.A. 90:1993;9576-9580.
7. Cepeda C., Colwell C.S., Itri J.N., Chandler S.H., Levine M.S. Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J. Neurophysiol. 79:1998;82-94.
8. Cepeda C., Radisavljevic Z., Peacock W., Levine M.S., Buchwald N.A. Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex. Synapse. 11:1992;330-341.
9. Chiodo L.A., Berger T.W. Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum. Brain Res. 375:1986;198-203.
10. Deakin J.F., Slater P., Simpson M.D., Gilchrist A.C., Skan W.J., Royston M.C., Reynolds G.P., Cross A.J. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52:1989;1781-1786.
11. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J. neural Transm. 36(Suppl.):1992;61-89.
12. Deutch A.Y., Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog. Brain Res. 85:1990;367-402.
13. 2 receptor by protein kinase C. J. Neurosci. 13:1993;4846-4853.
14. Dolan R.J., Fletcher P., Frith C.D., Friston K.J., Frackowiak R.S., Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature. 378:1995;180-182.
15. 2 dopamine receptor activation of a potassium channel in rat lactotrophs. J. Physiol., Lond. 462:1993;563-578.
16. Feenstra M.G., van der Weij W., Botterblom M.H. Concentration-dependent dual action of locally applied N-methyl-D-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo. Neurosci. Lett. 201:1995;175-178.
17. Finlay J.M., Zigmond M.J. The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem. Res. 22:1997;1387-1394.
18. Fraser D.D., Hoehn K., Weiss S., MacVicar B.A. Arachidonic acid inhibits sodium currents and synaptic transmission in cultured striatal neurons. Neuron. 11:1993;633-644.
19. 2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur. J. Neurosci. 7:1995;1050-1063.
20. Godukhin O.V., Zharikova A.D., Budantsev A. Role of presynaptic dopamine receptors in regulation of the glutamatergic neurotransmission in rat neostriatum. Neuroscience. 12:1984;377-383.
21. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
22. 1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J. Neurosci. 17:1997;5271-5280.
23. 2+ conductance. J. Neurosci. 17:1997;3334-3342.
24. Higashi H., Inanaga K., Nishi S., Uchimura N. Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pre-treatment. J. Physiol., Lond. 408:1989;587-603.
25. Jedema H.P., Moghaddam B. Glutamatergic control of dopamine release during stress in the rat prefrontal cortex. J. Neurochem. 63:1994;785-788.
26. 1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J. neural Transm. 86:1991;97-113.
27. Jones C.A., Zempleni E., Davis B., Reynolds G.P. Glutamate stimulates dopamine release from cortical and limbic rat brain in vitro. Eur. J. Pharmac. 242:1993;183-187.
28. Knable M.B., Weinberger D.R. Dopamine, the prefrontal cortex and schizophrenia. J. Psychopharmac. 11:1997;123-131.
29. Krieger N.R., Bunney B.S., Greengard P. Localization of dopamine-sensitive adenylate cyclase activity within laminae of the rat prefrontal cortex. Brain Res. 179:1979;171-175.
30. Krimer L.S., Jakab R.L., Goldman-Rakic P.S. Quantitative three-dimensional analysis of the catecholaminergic innervation of identified neurons in the macaque prefrontal cortex. J. Neurosci. 17:1997;7450-7461.
31. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B. Jr., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archs gen. Psychiat. 51:1994;199-214.
32. Kuroda M., Murakami K., Igarashi H., Okada A. The convergence of axon terminals from the mediodorsal thalamic nucleus and ventral tegmental area on pyramidal cells in layer V of the rat prelimbic cortex. Eur. J. Neurosci. 8:1996;1340-1349.
33. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 13:1995;9-19.
34. Law-Tho D., Hirsch J.C., Crepel F. Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study. Neurosci. Res. 21:1994;151-160.
35. 5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. J. Pharmac. exp. Ther. 281:1997;597-603.
36. 3H]SCH23390. Neuroscience. 40:1991;657-671.
37. Lidow M.S., Wang F., Cao Y., Goldman-Rakic P.S. Layer V neurons bear the majority of mRNAs encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse. 28:1998;10-20.
38. Malhotra A.K., Adler C.M., Kennison S.D., Elman I., Pickar D., Breier A. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biol. Psychiat. 42:1997;664-668.
39. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology. 17:1997;141-150.
40. Mercuri N., Bernardi G., Calabresi P., Cotugno A., Levi G., Stanzione P. Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms. Brain Res. 358:1985;110-121.
41. 1 receptors in schizophrenia revealed by PET. Nature. 385:1997;634-636.
42. Penit-Soria J., Audinat E., Crepel F. Excitation of rat prefrontal cortical neurons by dopamine: an in vitro electrophysiological study. Brain Res. 425:1987;263-274.
43. Przegalinski E., Filip M. Nitric oxide (NO) pathway and locomotor hyperactivity towards dopaminomimetics in rats. Pol. J. Pharmac. 49:1997;291-298.
44. Reid M.S., Hsu K. Jr., Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse. 27:1997;95-105.
45. 2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons. J. Neurochem. 62:1994;944-949.
46. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Curr. Opin. Neurol. Neurosurg. 6:1993;602-608.
47. Shi W.X., Rayport S. GABA synapses formed in vitro by local axon collaterals of nucleus accumbens neurons. J. Neurosci. 14:1994;4548-4560.
48. Shi W.X., Zheng P., Liang X.F., Bunney B.S. Characterization of dopamine-induced depolarization of prefrontal cortical neurons. Synapse. 26:1997;415-422.
49. 1-like dopamine receptors, involves protein kinase A and protein kinase C. Neuroscience. 68:1995;97-106.
50. Smiley J.F., Williams S.M., Szigeti K., Goldman-Rakic P.S. Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J. comp. Neurol. 321:1992;325-335.
51. 1 receptor stimulation: involvement of enhanced nitric oxide production via neurokinin-2 receptor activation. Neuroscience. 84:1998;511-518.
52. Tsai G., Passani L.A., Slusher B.S., Carter R., Baer L., Kleinman J.E., Coyle J.T. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Archs gen. Psychiat. 52:1995;829-836.
53. 2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2. J. Neurochem. 64:1995;2765-2772.
54. 2 receptors in rat medial prefrontal cortex. J. Neurosci. 13:1993;2551-2564.
55. 1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Molec. Pharmac. 48:1995;988-994.
56. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archs gen. Psychiat. 44:1987;660-669.
57. 2 dopamine receptor mRNA in rat brain. Proc. natn. Acad. Sci. U.S.A. 88:1991;1859-1863.
58. Wyatt R.J., Karoum F., Casanova M.F. Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia. Biol. Psychiat. 38:1995;4-12.
59. 1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J. Neurosci. 16:1996;1922-1935.
60. 1A receptor regulation of phospholipase C isoform. J. biol. Chem. 271:1996;19,503-19,508.
61. Yurko-Mauro K.A., Friedman E. Dopamine receptor stimulation decreases cytosolic gamma protein kinase C immunoreactivity in rat hippocampal slices: evidence for increased Ca(2+)-dependent proteolysis. J. Neurochem. 65:1995;1622-1630.